DBV Technologies SA (LTS:0QAJ) Transcripts
Half Year 2024 Dbv Technologies SA Earnings Call Transcript
Jul 30, 2024
€0.9455
(+5.17%)
Earnings
Full Year 2023 Dbv Technologies SA Earnings Call Transcript
Mar 07, 2024
€1.44
(-0.21%)
Earnings
Dbv Technologies SA to Discuss the EPOPEX Data Call Transcript
Nov 09, 2023
Q3 2023 Dbv Technologies SA Earnings Call Transcript
Oct 31, 2023
€2.13
(+3.20%)
Earnings
Half Year 2023 Dbv Technologies SA Earnings Call Transcript
Jul 31, 2023
€2.93
(-3.30%)
Earnings
Dbv Technologies SA at Goldman Sachs Healthcare Conference Transcript
Jun 14, 2023
Dbv Technologies SA at JMP Securities Life Sciences Conference Transcript
May 15, 2023
Dbv Technologies SA FDA Regulatory Call Transcript
Apr 19, 2023
Full Year 2022 Dbv Technologies SA Earnings Call Transcript
Mar 02, 2023
€2.83
(-2.01%)
Earnings
Q3 2022 Dbv Technologies SA Earnings Call Transcript
Nov 03, 2022
€2.99
(-0.07%)
Earnings
Dbv Technologies SA to Discuss the VITESSE Study Call Transcript
Sep 07, 2022
Dbv Technologies SA to Discuss Positive Topline Results from Phase 3 EPITOPE Trial Call Transcript
Jun 07, 2022
Q1 2022 DBV Technologies SA Earnings Call Transcript
May 02, 2022
Earnings
Full Year 2021 DBV Technologies SA Earnings Call Transcript
Mar 03, 2022
€2.73
(+14.63%)
Earnings
DBV Technologies SA Provides Update on Investigational Viaskinâ„¢ Peanut Corporate Call Transcript
Dec 20, 2021
Q3 2021 DBV Technologies SA Earnings Call Transcript
Oct 26, 2021
€8.77
(-2.28%)
Earnings
Half Year 2021 DBV Technologies SA Earnings Call Transcript
Aug 02, 2021
€9.14
(+0.18%)
Earnings
DBV Technologies SA at JMP Securities Life Sciences Virtual Conference Transcript
Jun 16, 2021
DBV Technologies SA at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 08, 2021
Full Year 2020 DBV Technologies SA Earnings Call Transcript
Mar 11, 2021
€8.93
(-3.28%)
Earnings
DBV Technologies SA at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 24, 2021
DBV Technologies SA To Provide An Update On Investigational Viaskin Peanut for Children Ages 4-11 Years Call Transcript
Jan 14, 2021
DBV Technologies SA at Evercore ISI HealthCONx Conference Transcript
Dec 01, 2020
DBV Technologies SA at Stifel Virtual Healthcare Conference Transcript
Nov 16, 2020
DBV Technologies SA at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 11, 2020
DBV Technologies SA at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020
DBV Technologies SA at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 09, 2020
DBV Technologies SA - Provides Update on Viaskin Peanut BLA for Children Ages 4-11 Years - Conference Call Transcript
Mar 16, 2020
DBV Technologies SA at Goldman Sachs Global Healthcare Conference Transcript
Jun 12, 2019
DBV Technologies SA at Bank of America Merrill Lynch Health Care Conference Transcript
May 14, 2019
DBV Technologies SA at Barclays Global Healthcare Conference Transcript
Mar 13, 2019
DBV Technologies SA To Provide Update on Regulatory Status of Viaskin Peanut for the Treatment of Peanut-Allergic Children Corporate Call Transcript
Feb 13, 2019